Figure 3.

Decreased ability to degrade NETs is associated with glomerulonephritis and altered laboratory variables. A-C. Odds ratios for co-occurrence of indicated parameters in SLE patients with a decreased ability to degrade NETs (n: 26), divided into SLEDAI-2K and clinical manifestations (A), laboratory variables (B) and medications (C) two months before (red), at the same time (black) or two month after (blue) the time point with decreased ability to degrade NETs. The odds ratios are indicated with a dot connected to the 95% confidence intervals. All values that do not cross "1" are considered significant. NETs, neutrophil extracellular traps; SLE, systemic lupus erythematosus; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2000

Leffler et al. Arthritis Research & Therapy 2013 15:R84   doi:10.1186/ar4264
Download authors' original image